Staff Reporters
Oct 20, 2010

Pharma giant Sanofi-Aventis retains Optimedia for US$450m media

GLOBAL - Sanofi-Aventis has retained Publicis Groupe's Optimedia for its global media account following a review.

Pharma giant Sanofi-Aventis retains Optimedia for US$450m media

The worldwide worth of the French pharmaceutical giant’s media spend is put at US$450 million, based on Nielsen estimates.

A review was reportedly held at the company’s headquarters in Paris, other agencies involved were not disclosed.

Sanofi-Aventis brands include Plavix, Lantus, Maalox, Frontline and Heartgard.

Source:
Campaign Asia

Related Articles

Just Published

10 hours ago

Creative Minds: Heidi Kasselman on how pretending ...

From winging an internship in Johannesburg to leading creative at Clemenger, Heidi Kasselman's unconventional path proves sometimes chaos is the best career plan.

11 hours ago

Veteran Australian broadcaster Alan Jones arrested ...

One of the country's most influential yet controversial media figures, Jones has been detained following an investigation into alleged offences spanning nearly two decades.

11 hours ago

40 Under 40 2024: Jacob Lin, Leap Strategy

A 29-year-old CEO, Lin is redefining digital marketing in China, blending purpose with profit to transform brand engagement with talent and consumers alike.

11 hours ago

Agency of the Year 2024: Shortlists announced

See the full shortlist for the 2024 Campaign Asia-Pacific Agency of the Year awards here. Tickets are limited, we encourage you to secure your spot fast.